Get the Stockscreener App
4.55
0.44%
0.02
After Hours:
4.43
-0.12
-2.64%
Cumberland Pharmaceuticals Inc stock is traded at $4.55, with a volume of 300.70K.
It is up +0.44% in the last 24 hours and up +43.53% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
See More
Previous Close:
$4.53
Open:
$4.48
24h Volume:
300.70K
Relative Volume:
0.32
Market Cap:
$68.05M
Revenue:
$44.52M
Net Income/Loss:
$-2.86M
P/E Ratio:
-23.80
EPS:
-0.1912
Net Cash Flow:
$4.75M
1W Performance:
+6.31%
1M Performance:
+43.53%
6M Performance:
+95.28%
1Y Performance:
+1.79%
1-Day Range:
$4.48
$4.75
1-Week Range:
$4.07
$4.75
52-Week Range:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
4.55 | 67.75M | 44.52M | -2.86M | 4.75M | -0.1912 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Earnings Results - MarketBeat
Cumberland Pharmaceuticals Sells FDA-Approved Brands for $100 Million to Apotex, Reports Q1 2026 Financial Results and Focuses on Orphan Drug Pipeline 1 - Minichart
Cumberland Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Inc. (CPIX) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
Earnings call transcript: Cumberland Pharmaceuticals Q1 2026 shows mixed results - Investing.com
Cumberland: Q1 Earnings Snapshot - kens5.com
Full Transcript: Cumberland Q1 2026 Earnings Call - Benzinga
Cumberland Pharmaceuticals (CPIX) sets $100M brand sale as Q1 2026 turns to loss - Stock Titan
$100M Apotex deal would leave Cumberland focused on orphan drugs - Stock Titan
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Apotex Affiliate to Acquire Cumberland Pharmaceutical Portfolio for $100M - HarianBasis.co
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex - Insider Monkey
Q&A: A.J. Kazimi, Cumberland Pharmaceuticals - Nashville Post
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - Weekly Voice
After the bell May 5: Cumberland to host Q1 update at 4:30 ET - Stock Titan
Cumberland Pharmaceuticals (CPIX) Expected to Announce Earnings on Tuesday - MarketBeat
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Shareholders Back Board, Auditor and Pay Policies - The Globe and Mail
Cumberland Pharmaceuticals Inc. Files 8-K Report with SEC Detailing Company Information and Shareholder Vote Results - Minichart
Cumberland Pharmaceuticals Shares Surge 80 Percent After Apotex Deal - HarianBasis.co
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Cumberland Pharmaceuticals shareholders approve board nominees and other proposals - Investing.com
Shareholders at Cumberland (NASDAQ: CPIX) back board, auditor and pay - Stock Titan
Crude Oil Gains Over 1%; US Initial Jobless Claims Edge Higher - Sahm
Apotex inks strategic transaction with Cumberland Pharma - The Pharma Letter
Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson
Cumberland to sell drug portfolio to Apotex for $100m - Pharmaceutical Technology
Cumberland Pharmaceuticals stock soars on $100M Apotex deal By Investing.com - Investing.com South Africa
CPIX Price Today: Cumberland Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Cumberland shares soar on $100M deal announcement - Nashville Post
Apotex Inc. enter into Asset Purchase Agreement to acquire Certain assets related to certain pharmaceutical products of Cumberland Pharmaceuticals Inc. for $100 million. - marketscreener.com
Cumberland Pharmaceuticals (CPIX) jumps on $100 million Apotex asset-sale deal - Quiver Quantitative
Cumberland Pharmaceuticals sells drug portfolio for $100M to Canadian giant - The Business Journals
Cumberland Pharmaceuticals (CPIX) Stock: Soars 57% After $100M Apotex Deal Announcement - parameter.io
Cumberland Pharmaceuticals to sell branded drug unit to Apotex for $100M - Investing.com
CPIX Jumps As FDA Expands Caldolor Postoperative Pain Label - StocksToTrade
Cumberland Pharmaceuticals to sell branded drug unit to Apotex for $100M By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals Sells Branded Portfolio to Apotex for $100 Million, Refocuses on Orphan Drug Development - Minichart
Cumberland Divests Branded Assets, Refocuses on Orphan Drugs - TipRanks
CPIX Stock Pops As FDA Expands Caldolor Pain Drug Label - timothysykes.com
Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses - PR Newswire
Cumberland Pharmaceuticals stock soars on $100M Apotex deal - Investing.com
Cumberland Pharmaceuticals to Sell Branded Product Assets to Apotex for $100 Million - TradingView
[8-K] CUMBERLAND PHARMACEUTICALS INC Reports Material Event - Stock Titan
Cumberland takes $100M cash deal, keeps three Phase II programs - Stock Titan
Dow Falls Over 200 Points; Tesla Shares Slip After Q1 Results - Sahm
Intravenous (IV) Ibuprofen Market Outlook 2026-2033: Growth - openPR.com
Is Cumberland (CPIX) stock a viable buying opportunity (+4.53%) 2026-04-18Community Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
Cumberland Pharmaceuticals gets FDA nod for expanded Caldolor use By Investing.com - Investing.com Australia
Cumberland Pharmaceuticals gets FDA nod for expanded Caldolor use - Investing.com
Cumberland Pharmaceuticals Inc Announces Expanded Indication for Caldolor Ibuprofen Injection - marketscreener.com
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):